Skip to main content

Notification · DGFT

NOTIFICATION NO. 35/2024, DT. 01/10/2024

Dated
01 Oct 2024
Reference no.
35/2024-25

Amendment in Export Policy condition of Cough Syrup under Chapter 30 of Schedule-II (Export Policy) of ITC (HS) 2022-reg.

(To be published in the Gazette of India Extraordinary Part-II, Section - 3, Sub-Section (ii))

Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade Vanijya Bhawan, New Delhi
Notification No. 35/2024-25

New Delhi, Dated: 1" October 2024

Subject: Amendment in Export Policy condition of Cough Syrup under Chapter 30 of

Schedule-II (Export Policy) of ITC (HS) 2022-reg.

In exercise of powers conferred by Section 3 read with section 5 of the Foreign Trade (Development & Regulation) Act, 1992, read with Para 1.02 and 2.01 of the Foreign Trade Policy 2023, as amended from time to time, and in continuation of the Notification No. 06/2023 dated 22.05.2023, the Central Government amends the Export Policy condition for HSN 3004 under Chapter 30, Schedule-II (Export Policy) of ITC(HS) 2022, with immediate effect as under:

Policy Existing Policy Condition Revised Policy Condition —

INo.

1 [Cough Syrup shall be permitted to Ki) Cough Syrup shall be permitted to be be exported subject to the export |exported subject to the export sample being sample being tested and tested and production of Certificate of production of Certificate of Analysis (CoA) issued by any of the following Analysis (CoA) issued by any of |laboratories:

ithe following laboratories: . ; cis e Indian Pharmacopoeia Commission,

e Indian Pharmacopoeia Ghaziabad, Uttar Pradesh Commission, Ghaziabad,

Uttar Pradesh e CDL, Kolkata, West Bengal + CDL, Kolkata, West e CDTL, Chennai, Tamil Nadu Bengal e CDTL, Mumbai, Maharashtra
e CDTL, Chennai, Tamil
Nadu
e CDTL, Hyderabad, Telangana
e RDTL, Chandigarh
e CDTL, Mumbai,

Maharashtra e RDTL, Guwahati, Assam e CDTL, Hyderabad, e Any NABL accredited State Drugs Telangana Testing Laboratory
e RDTL, Chandigarh * Bee Pharmo Labs Pvt. Ltd Thane, C 2 Hatkesh Udyog Nagar, Mira
a

* RDTL, Guwahati, Assam
Any NABL accredited
State Drugs Testing
Laboratory
Bee Pharmo Labs Pvt. Ltd
Thane, C 2 Hatkesh
Udyog Nagar, Mira
Bhayander Road, Mira
Road (East), thane-
401107, Maharastra.

Oasis Test House, 24-A, B
Sardar Patel, industrial
Estate, Narol, Ahmedabad-
382407, Gujarat.

Shriram Institute for
Industrial Research (A unit
of Shriram Scientific and
Industrial Research
Foundation), 19-
University Road, New
Delhi-110007
Bhayander Road, Mira Road (East),

thane-401107, Maharastra.

Oasis Test House, 24-A, B Sardar
Patel, industrial Estate, Narol,

Ahmedabad-382407, Gujarat.

e Shriram Institute for Industrial
Research (A unit of Shriram Scientific and Industrial Research Foundation),

19-University Road, New Delhi-
110007

(ii) In case, the manufacturers are exporting jthe Cough Syrup to USA, UK, Canada, EU,

Japan, Australia, Singapore, Republic of Korea and Switzerland, the requirement of testing from the laboratories mentioned at (i) above may be waived off, in view of approval granted by these countries’ regulatory agencies for plants/section engaged in manufacturing and export of Cough Syrup.

(iii) Further, if Cough Syrup is manufactured in a plant/section approved by the regulatory lagencies for above mentioned countries at (ii) for any product, such Cough Syrup shall be permitted to be exported to any country lwithout testing as mandated at (i) above.

Effect of this Notification: The mandatory testing of the export sample of ‘Cough Syrup’ under HSN 3004 is exempted in certain situations as mentioned above in accordance with the required GMP benchmarks/standards.

Ro 700
(Santosh Kumar Sarangi)

Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India E-mail: dgft@nic.in
(Issued from F. No. 01/91/180/21/AM20/EC/Part-VII/e- 21207)

Source: Directorate General of Foreign Trade (DGFT). View the official PDF.